4Roglans N, Vazquez-Carrera M, Alegret M, et al. Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients. Eur J Clin Pharmacol,2004, 59: 855-861.
5Fuchs M, Ivandic B, Muller O, et al. Biliary cholesterol hypersccretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI. Hepatology,2001, 33: 1451-1459.
6Lea AP, McTavish D, Atorrastatin, et al. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs, 1997, 53: 828-831.
7Kawaii S, Tomono Y, Katase E, et al. Acridones as inducers of HL60 cell differentiation. Leukemia Res, 1999, 23: 263-269.
二级参考文献29
1Paigen B. Genetics of responsiveness to high-cholesterol diets in the mouse. Am J Clin Nutr 1995;62:458-462.
2Lammert F, Carey MC, Paigen B. Chromosomal organization of cadinate genes involved in cholesterol gallstone formation:a murine gallstone map. Gastroenterology 2001;120:221-238.
3Roglans N, Vazquez-Carrera M, Alegret M, Novell F, Zambon D, Ros E, Laguna JC, Sanchez RM. Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients. Eur J Clin Pharmacol 2004;59:855-861.
4Friesen JA, Rodwell VW. The 3-hydroxy-3-methylglutaryl co-enzyme-A(HMG-CoA)reductases. Genome Biol 2004;5:248.
5Stolowich NJ, Petrescu AD, Huang H, Martin GG, Scott AI,Schroeder F. Sterol carrier protein-2: structure reveals function.Cell Mol Life Sci 2002;59:193-212.
6Atshaves BP, Storey SM, McIntosh AL, Petrescu AD,Lyuksyutova OI, Greenberg AS, Schroeder F. Sterol carrier protein-2 expression modulates protein and lipid composition of lipid droplets.J Biol Chem 2001;276:25324-25335.
7Gallegos AM, Atshaves BP, Storey SM, McIntosh AL, Petrescu AD, Schroeder F. Sterol carrier protein-2 expression alters plasma membrane lipid distribution and cholesterol dynamics.Biochemistry 2001;40:6493-6506.
8Gallegos AM, Schoer JK, Starodub O, Kier AB, Billheimer JT,Schroeder F. A potential role for sterol carrier protein-2 in cholesterol transfer to mitochondria. Chem Phys Lipids 2000;105:9-29.
9Diehl AK, Schwesinger WH, Holleman DR Jr, Chapman JB,Kurtin WE. Clinical correlates of gallstone composition:distinguishing pigment from cholesterol stones. Am J Gastroenterol 1995;90:967-972.
10Portincasa P, Moschetta A, Calamita G, Margari A, Palasciano G. Pathobiology of cholesterol gallstone disease:from equilibrium ternary phase diagram to agents preventing cholesterol crystallization and stone formation. Curr Drug Targets Immune Endocr Metabol Disord 2003;3:87-68.
